;

Articles Not Curated - Sequence
Last updated: 2025 Mar 18
Total hit(s): 7018
S.No.
1
39643949
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia.
Expert Rev Vaccines
2025 Dec
4.37
1
2
39834144
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants.
Expert Rev Vaccines
2025 Dec
4.37
1
3
40045463
The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants.
Hum Vaccin Immunother
2025 Dec
4.7
1
4
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
5
40046771
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct.
J Struct Biol X
2025 Jun
1
6
39987705
Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies.
Biophys Chem
2025 May-Jun
1.75
1
7
39847906
Hyperplex PCR enables highly multiplexed analysis of point mutations in wastewater: Long-term SARS-CoV-2 variant surveillance in Sweden as a case study.
Water Res
2025 Apr 15
8.14
1
8
40043614
Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
Biochem Biophys Res Commun
2025 Apr 1
2.73
1
9
40025551
Association of TNFRSF13B Gene Polymorphisms With SARS-CoV-2 Infection, Severity, and Humoral Immune Response in a Moroccan Population.
Int J Immunogenet
2025 Apr
1
10
40057761
Impact of single nucleotide polymorphism of IL-27P28 rs153109 and IFITM3 rs12252 on susceptibility and severity of COVID-19 in Egyptian patients: a case control study.
Virol J
2025 Mar 8
2.45
1
11
40056806
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Vaccine
2025 Mar 7
3.31
1
12
40058446
Carbon monoxide inhibits human bronchial epithelial CCL5 and IL-6 secretion induced by SARS-CoV-2 spike RBD protein.
Exp Cell Res
2025 Mar 7
3.24
1
13
39973207
Reactive oxygen species-mediated cytotoxic and DNA-damaging mechanism of N(4)-hydroxycytidine, a metabolite of the COVID-19 therapeutic drug molnupiravir.
Free Radic Res
2025 Mar 6
1
14
40054138
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.
Vaccine
2025 Mar 6
3.31
1
15
40044817
Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2.
Nat Biomed Eng
2025 Mar 5
31.8
1
16
40044856
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences.
Nature
2025 Mar 5
24.36
1
17
40038251
LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment.
Nat Commun
2025 Mar 4
11.8
1
18
39962897
Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain.
Inorg Chem
2025 Mar 3
1
19
40044551
Electrochemical pan-variant detection of SARS-CoV-2 through host cell receptor-mimicking molecular recognition.
Biosens Bioelectron
2025 Mar 3
9.52
1
20
40025489
Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection.
BMC Biol
2025 Mar 3
1
21
40060909
Mutational pressure promotes release of public CD8(+) T cell epitopes by proteasome from SARS-CoV-2 RBD of Omicron and its current lineages.
iScience
2025 Mar 21
4.447
1
22
40034851
Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimated perniciousness of severe acute respiratory syndrome coronavirus 2 EG.1 variant.
iScience
2025 Mar 21
4.447
1
23
40096751
Efficient one-step immobilization of DNA probes on 1DZnO nanoplatforms targeting a low-mutation region of SARS-CoV-2.
Biofabrication
2025 Mar 17
1
24
40072429
Estimation and Hypothesis Testing of Strain-Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID-19 Vaccine Trial.
Stat Med
2025 Mar 15
3.1
1
25
40085715
SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding.
Sci Adv
2025 Mar 14
16.4
1